Wearable Robotics, a Pisa-based developer of wearable robotic exoskeletons for upper limb rehabilitation and industrial load handling, has raised €5 million ($5.8M) in Series A funding led by CDP Venture Capital. The company offers products like the CE-certified ALEx RS active exoskeleton with VR integration and the LBE30 for heavy lifting. The capital will expand product portfolios, regulatory compliance, sales channels, and North American markets.
Exoskeleton Series A Wave Accelerates
The funding aligns with rising investor interest in wearable robotics. HeroWear raised $5M Series A in April 2024 for occupational exosuits, while Wandercraft secured $75M Series D in June 2024 for self-balancing exoskeletons per Exoskeleton Report. Wearable Robotics' tendon-actuated, lightweight designs target upper limb neurorehab gaps unmet by lower-body focused rivals.
Stroke Cases Fuel Rehab Demand
Rising stroke and neurological disorders drive need for advanced rehab tools. An aging population in Europe amplifies demand for non-invasive upper limb recovery solutions. Current therapies often lack engagement and precision, leading to suboptimal patient outcomes.
Tendon Tech Enables Lightweight Mobility
Wearable Robotics' ALEx RS provides 5 degrees of freedom with VR for immersive neuro-motor rehab, installed in over 50 units across 20 countries. The passive ALEx S and industrial LBE30/MMC EXOS support up to 40kg loads effortlessly. Patented actuation reduces weight versus EMG or rigid competitors like Myomo's orthoses.
As Lucia Lencioni, CEO noted:
"The completion of this funding round marks a crucial step in our development."
Sant'Anna Spin-Off Secures Growth Capital
CDP Venture Capital's Acceleratori Fund led, with MITO Technology, Liftt, Simest, RoboIT, and Toscana Next joining. This mix signals public-private support for Italian deeptech, emphasizing social impact in rehab. Investors back scaling clinical validation and global sales.
Exoskeleton Market Nears $2B
The exoskeleton market stands at $590M in 2025, projected to reach $1.79B by 2033 at 14.5% CAGR per Grand View Research. Lightweight designs and AI integration propel growth amid post-COVID rehab surges. Wearable Robotics positions in the upper limb niche, cross-pollinating medical and industrial tech.
Elite Robotics Lab Powers Team
Co-founder Antonio Frisoli, full professor at Scuola Superiore Sant'Anna, heads the PERCRO lab from which Wearable Robotics spun out, acquiring 8 patents in 2022. CEO Lucia Lencioni drives commercialization of CE Class IIa devices. The 22-person team blends academic R&D with ops expertise from pharma.
North America Entry Gains Traction
Plans target North American expansion, already with first ALEx RS installations there and recent Spain rollout. Funding accelerates modular robotics, regulatory processes, and commercial channels. Events like Medica 2024 and SPS Italia showcase LBE30 advancements.